Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

932 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Spinal cord involvement in Behçet's disease.
Lee HS, Kim do Y, Shin HY, Choi YC, Kim SM. Lee HS, et al. Among authors: shin hy. Mult Scler. 2016 Jun;22(7):960-3. doi: 10.1177/1352458515613642. Epub 2015 Oct 19. Mult Scler. 2016. PMID: 26480923
Acute bulbar palsy as a variant of Guillain-Barré syndrome.
Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Oh J, Suh BC, Yoon BA, Park HT, Huh SY, Oh SI, Bae JS; Korean Inflammatory Neuropathy Consortium. Kim JK, et al. Among authors: shin hy, shin kj. Neurology. 2016 Feb 23;86(8):742-7. doi: 10.1212/WNL.0000000000002256. Epub 2015 Dec 30. Neurology. 2016. PMID: 26718574
A multicenter prospective observational study on the safety and efficacy of tacrolimus in patients with myasthenia gravis.
Ahn SW, Joo IS, Kim BJ, Sung JJ, Kang SY, Oh J, Minn YK, Suh BC, Oh SY, Hong YH, Nam TS, Seok JI, Park YE, Shin HY, Cho EB, Shin JY, Seok HY, Park JS, Min JH, Seok JM, Kim BJ. Ahn SW, et al. Among authors: shin hy, shin jy. J Neurol Sci. 2017 Aug 15;379:271-275. doi: 10.1016/j.jns.2017.05.060. Epub 2017 May 30. J Neurol Sci. 2017. PMID: 28716258
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
Howard JF Jr, Utsugisawa K, Benatar M, Murai H, Barohn RJ, Illa I, Jacob S, Vissing J, Burns TM, Kissel JT, Muppidi S, Nowak RJ, O'Brien F, Wang JJ, Mantegazza R; REGAIN Study Group. Howard JF Jr, et al. Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20. Lancet Neurol. 2017. PMID: 29066163 Clinical Trial.
Neutralizing Antibodies Against Interferon-Beta in Korean Patients with Multiple Sclerosis.
Hyun JW, Kim G, Kim Y, Kong B, Joung A, Park NY, Jang H, Shin HJ, Kim SH, Ahn SW, Shin HY, Huh SY, Kim W, Park MS, Kim BJ, Kim BJ, Oh J, Kim HJ. Hyun JW, et al. Among authors: shin hj, shin hy. J Clin Neurol. 2018 Apr;14(2):186-190. doi: 10.3988/jcn.2018.14.2.186. Epub 2018 Feb 28. J Clin Neurol. 2018. PMID: 29504299 Free PMC article.
Clinical Heterogeneity of Anti-GM2-Ganglioside-Antibody Syndrome.
Kim JK, Kim YH, Yoon BA, Cho JY, Oh SY, Shin HY, Kim JS, Park KH, Kim SY, Suh BC, Seok HY, Yoo JH, Bae JS. Kim JK, et al. Among authors: shin hy. J Clin Neurol. 2018 Jul;14(3):401-406. doi: 10.3988/jcn.2018.14.3.401. J Clin Neurol. 2018. PMID: 29971981 Free PMC article.
932 results